SAN
DIEGO, May 13, 2024 /PRNewswire/ -- ChemDiv, Inc,
announced today that Bill Farley,
CEO, will participate in the EF Hutton Annual Global Conference
(https://efhutton.com/conference/). The conference is being held in
person at The Plaza Hotel, NY, NY 10019 on May 15, 2024.
Bill Farley, CEO of ChemDiv, will
provide corporate updates and highlights associated with ChemDiv's
growth and development through partnerships with multiple venture
backed accelerators, leveraging AI/LLM, chemical libraries,
integrated biology and development with over 26 assets in the
pipeline. These assets cover a broad range of therapeutic areas
such as oncology, inflammation, CVMD, and
anti-infectives.
About ChemDiv Inc
ChemDiv is a globally recognized leader in drug discovery
solutions, offering fully integrated R&D services to support
pharmaceutical projects. With over three decades of experience,
ChemDiv delivers leads, drug candidates, and new drugs across
various therapeutic areas to partners worldwide.
For more information about ChemDiv visit www.chemdiv.com.
For media inquiries, please contact:
Bill Farley
CEO of ChemDiv
bfarley@chemdiv.com
View original
content:https://www.prnewswire.com/news-releases/chemdiv-to-participate-in-the-ef-hutton-annual-global-conference-may-15-2024-302143637.html
SOURCE ChemDiv